Fluorogenic peptide substrates for carboxydipeptidase activity of cathepsin B

Acta Biochimica Polonica

Volumn 51, Issue 1, 2004, Pages 81-92

  Stachowiak, Krystyna ^a   Tokmina, Monika ^a   Karpińska, Anna ^a   Sosnowska, Renata ^a   Wiczk, Wiesław ^a  

^a UNIVERSITY OF GDA SK   (Poland)

Author keywords

Cathepsin B; Cystatins; Fluorogenic substrate

Indexed keywords

CATHEPSIN B; CYSTATIN; CYSTATIN C; DIPEPTIDYL CARBOXYPEPTIDASE; ENZYME; GLUTAMINE; PAPAIN; VALINE;

ACIDITY; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CATALYSIS; ENERGY TRANSFER; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME BINDING; ENZYME KINETICS; ENZYME SPECIFICITY; ENZYME SUBSTRATE; ENZYME SYNTHESIS; FLUORESCENCE ANALYSIS; MICHAELIS CONSTANT; MONITORING; PH MEASUREMENT; PROTEIN HYDROLYSIS;

EID: 2342476368     PISSN: 0001527X     EISSN: None     Source Type: Journal    
DOI: 10.18388/abp.2004_3599     Document Type: Article

References (39)

1. Barlos K, Chatzi O, Gatos D, Stavropoulos G. (1991) 2-Chlorotrityl chloride resin. Studies on anchoring of Fmoc-amino acids and peptide cleavage. Int J Pept Protein Res.; 37: 513-20.
2. Barrett AJ, Kembahavi AA, Brown MA, Kirschke H, Knight CG, Tamai M, Hanada K. (1982) L-Trans-epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. Biochem J.; 201: 189-98.
3. Berdowska I, Siewiński M. (2000) Rola katepsyn cysteinowych oraz ich inhibitorów w procesach fizjologicznych i nowotworowych. Post Biochem.; 46: 73-84 (in Polish).
4. Blumberg S, Schechter I, Berger A. (1970) The purification of papain by affinity chromatography. Eur J Biochem.; 15: 97-102.
5. Bodanszky M, Bodanszky A. (1984) The Practice of Peptide Chemistry, pp 143. Springer-Verlag, New York.
6. Dörner B, White P. (2000) Synthesis Notes. In Novabiochem Catalog. (a) pp P33, (b) pp S15. CN Bioscience, Inc., An Affiliate of Merck KgoA, Darmstadt, Germany.
7. Grubb A. (2000) Cystatin C - properties and use as diagnostic marker. Adv Clin Chem.; 35: 63-99.
8. Grzonka Z, Jankowska E, Kasprzykowski F, Kasprzykowska R, Łankiewicz L, Wiczk W, Wieczerzak E, Ciarkowski J, Drabik P, Janowski R, Kozak M, Jaskólski M, Grubb A. (2001) Structural studies of cysteine proteases and their inhibitors. Acta Biochim Polon.; 48: 1-20.
9. Henskens YMC, Veerman ECI, Amerongen AV. (1996) Cystatins in health and disease. Biol Chem Hoppe-Seyler.; 377: 71-86.
10. Hilaire Ph, Willert M, Juliano M, Juliano L, Meldal M. (1999) Fluorescence-quenched solid phase combinatorial libraries in the characterization of cysteine protease substrate specificity. J Comb Chem.; 1: 509-23.
11. Illy C, Quraishi O, Wang J, Purisima E, Vernet T, Mort J. (1997) Role of the occluding loop in cathepsin B activity. J Biol Chem.; 272: 1197-202.
12. Jutras I, Reudelhuber TL. (1999) Prorenin processing by cathepsin B in vitro and in transfected cells. FEBS Lett.; 443: 48-52.
13. Katunuma N, Matsunaga Y, Matsui A, Kakegawa H, Endo K, Inubushi T, Saibara T, Ohba Y, Kakiuchi T. (1998) Novel physiological functions of cathepsins B and L on antigen processing and osteoclastic bone resorption. Adv Enzyme Regul.; 38: 235-51.
14. Keppler D, Sameni M, Moin K, Mikkelsen T, Diglio CA, Sloane BF. (1996) Tumor progression and angiogenesis. Biochem Cell Biol.; 74: 799-810.
15. Lalmanach G, Serveau C, Brillard-Bourdet M, Chagas J, Mayer R, Juliano L, Gauthier F. (1995) Conserved cystatin segments as models for designing specific substrates and inhibitors of cysteine proteinases. J Protein Chem.; 14: 645-53.
16. Liberek B, Kasprzykowska R. (1987) Oxidation products of L-lysine derivatives as starting materials for peptide synthesis and for the preparation of homoglutamic acid, homoglutamine and homoisoglutamine. Int J Peptide Protein Res.; 30: 522-32.
17. Mort JS, Buttle DJ. (1997) Cathepsin B. J Biochem Cell Biol.; 29: 715-20.
18. Musil D, Zucic D, Turk D, Engh RA, Mayr I, Huber R, Popovic T, Turk V, Towatari T, Katunuma N, Bode W. (1991) The refined 2.15 Å X-ray crystal structure of human liver cathepsin B: the structural basis for its specificity. EMBO J.; 10: 2321-30.
19. Nägler D, Storer A, Portaro F. Carmona E, Juliano L, Menard R. (1997) Major increase in endopeptidase activity of human cathepsin B upon removal of occluding loop contacts. Biochemistry.; 36: 12608-15.
20. Nägler D, Tam W, Storer A, Krupa J, Mort J, Ménard R. (1999) Interdependency of sequence and positional specificities for cysteine proteases of the papain family. Biochemistry.; 38: 4868-74.
21. Nawrocka M, Tokmina M, Wiczk W, Stachowiak K. (2001) Intramolecularly quenched fluorogenic peptide substrates for cathepsin B. In Peptides 2000, Proc. of 26th European Peptide Symposium. Martinez J, Fehrentz JA, eds, pp 566-7. EDK, Paris.
22. Neises B, Steglick W. (1978) Simple methods for the esterification of carboxylic acids. Angew Chem Int Ed Engl.; 17: 523-54.
23. Nycander M, Estrada S, Mort JS, Abrahamson M, Björk I. (1998) Two-step mechanism of inhibition of cathepsin B by cystatin C due to displacement of the proteinase occluding loop. FEBS Lett.; 422: 61-4.
24. Otto HH, Schirmeister T. (1997) Cysteine proteases and their inhibitors. Chem Rev.; 97: 133-72.
25. Pavlova A, Krupa J, Mort J, Abrahamson M, Bjork I. (2000) Cystatin inhibition of cathepsin B requires dislocation of the proteinase occluding loop. Demonstration by release of loop anchoring through mutation of His110. FEBS Lett.; 487: 156-60.
26. Pohl J, Davinic S, Blaha I, Strop P, Kostka V. (1987) Chromophoric and fluorophoric peptide substrates cleaved through the dipeptidyl carboxypeptidase activity of cathepsin B. Anal Biochem.; 95: 228-35.
27. 3′ variations in extended substrates. Biochem J.; 347: 123-9.
28. Quraishi O, Nägler D, Fox T, Sivaraman J, Cygler M, Mort J, Storer A. (1999) The occluding loop in cathepsin B defines the pH dependence of inhibition by its propeptide. Biochemistry.; 38: 5017-23.
29. Stachowiak K, Tokmina M, Kasprzykowska R, Kasprzykowski F, Wiczk W. (2001) Inhibition of cathepsin B by aldehyde derivatives of cystatins N-terminal binding fragments. In Programme and abstracts of IPS International Conference on Protease Inhibitors, p 185. Munich, Germany.
30. 2SO and incubation time on papain activity studied using fluorogenic substrates. Acta Biochim Polon.; 48: 995-1002.
31. Schechter I, Berger A. (1967) On the size of the active site in proteases. I. Papain. Biochem Biophys Res Commun.; 27: 157-162.
32. Turk D, Guncar G, Podobnik M, Turk B. (1998) Revised definition of substrate binding sites of papain-like cysteine proteases. Biol Chem.; 379: 137-47.
33. Vogel A. (1984) Textbook of Practical Organic Chemistry. pp 611-612, WNT, Warsaw (in Polish).
34. Warwas M, Haczyńska H. (1998) Rola cystatyn w procesie nowotworowym i jego diagnostyce. Post Hig Med Dośw.; 52: 515-26 (in Polish).
35. Wenschuh H, Beyermann M, Winter R, Bienert M, Ionescu D, Carpino LA. (1996) Fmoc amino acid fluorides in peptide synthesis - extension of the method to extremely hindered amino acids. Tetrahedron Lett.; 37: 5483-5.
36. Wieczerzak E, Drabik P, Łankiewicz L, Ołdziej S, Grzonka Z, Abrahamson M, Grubb A, Brömme D. (2002) Azapeptides structurally based upon inhibitory sites of cystatins as potent and selective inhibitors of cysteine proteases. J Med Chem.; 45: 4202-11.
37. Wijffels GL. (1998) Cathepsin B. In Handbook of Proteolytic Enzymes. Barrett AJ, Rawlings ND, Woessne, JF. eds, pp 609-17. Academic Press, San Diego, London, Boston, New York, Sydney, Tokyo, Toronto.
38. Yamamoto A, Tomoo K, Hara T, Murata M, Kitamura K, Ishida T. (2000) Substrate specificity of bovine cathepsin B and its inhibition by CA074, based on crystal structure refinement of the complex. J Biochem.; 127: 635-43.
39. Zore I, Krasovec M, Cimerman N, Kuhelj R, Werle B, Nielsen H, Brunner N, Kos J. (2001) Cathepsin B/cystatin C complex levels in sera from patients with lung and colorectal cancer. Biol Chem.; 382: 805-10.